Skip to content
ppharmaranks
Menu

Best treatments for onchocerciasis

3 products may treat onchocerciasis, spanning FDA drug classes such as antiparasitic, pediculicide. The current highest-rated option is sklice. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 3 drugs we list for onchocerciasis, all are available as lower-cost generics, spanning classes such as antiparasitic, pediculicide. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for onchocerciasis — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 15, 2026·How we rate

Top-rated picks for onchocerciasis: 1. Sklice · 2. Stromectol · 3. Soolantra

Top-rated treatments for onchocerciasis, ranked by pharmaranks score
#DrugRatingPharmacy pays
170/100$3View →
270/100$3View →
3Not yet rated$3View →

Narrow by drug class

Explore the class hubs: antiparasitic

Full ranking · 3 treatments

Frequently asked

What treats onchocerciasis?
Our catalog lists 3 products that may treat onchocerciasis, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is sklice.
What is the best-rated treatment for onchocerciasis?
By our independent recall-safety rating — not an efficacy measure — sklice ranks highest among the products we list for onchocerciasis. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat onchocerciasis?
Treatments for onchocerciasis span FDA drug classes including antiparasitic, pediculicide. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.